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Summary
Treatment of carotid artery stenosis decreases the long-
term risk of stroke and may enhance cerebral blood flow. It
is therefore expected to have the potential to prevent cog-
nitive decline or even improve cognition over the long-
term. However, intervention itself can cause peri-interven-
tional cerebral infarcts, possibly resulting in a decline of
cognitive performance, at least for a short time. We invest-
igated the long-term effects of three treatment methods on
cognition and the emotional state one year after interven-
tion.
In this prospective observational cohort study, 58 patients
with extracranial carotid artery stenosis (≥70%) underwent
magnetic resonance imaging and assessment of cognition,
mood and motor speed before carotid endarterectomy (n =
20), carotid stenting (n = 10) or best medical treatment (n
= 28) (i.e., time-point 1 [TP1]), and at one-year follow-up
(TP2). Gain scores, reflecting cognitive change after treat-
ment, were built according to performance as (TP2 −TP1)/
TP1.
Independent of the treatment type, significant improvement
in frontal lobe functions, visual memory and motor speed
was found. Performance level, motor speed and mood at
TP1 were negatively correlated with gain scores, with
greater improvement in patients with low performance be-
fore treatment.
Active therapy, whether conservative or interventional,
produces significant improvement of frontal lobe functions
and memory in patients with carotid artery disease, inde-
pendent of treatment type. This effect was particularly pro-
nounced in patients with low cognitive performance prior
to treatment.
Key words: carotid artery stenosis; cognitive function;
emotional state; endarterectomy; stenting; best medical
treatment
Introduction
Cognitive performance is an important outcome measure of
carotid artery treatment and affects patient well-being and
quality of life. High-grade stenosis of the carotid artery is
associated with cognitive impairment [1], even when there
is no evidence of infarction on magnetic resonance ima-
ging (MRI). Likely mechanisms for such cognitive effects
are multiple and include embolisation and chronic or inter-
mittent hypoperfusion distal to the stenosis. Interestingly,
some patients display normal cognitive performance des-
pite severe carotid artery disease [1]. At present, carotid
artery disease is usually treated with carotid endarterec-
tomy (CEA), carotid artery stenting (CAS) or best medical
treatment (BMT).
Reports on the effect of carotid artery treatment on cog-
nition are inconsistent. Some studies claim an increase of
cognitive performance after CEA in certain cognitive do-
mains [2, 3], others propose a cognitive decline [4, 5], and
some describe no performance change after CEA [6]. Re-
cent reviews [7–9] concluded that neither CEA nor CAS
clearly affected cognition in general and that there were no
differences in overall cognitive functioning after CEA or
CAS. However, a definitive conclusion regarding the effect
of CAS versus CEA on cognitive function is impossible
owing to heterogeneity in definition, method, timing of as-
sessment and type of cognitive tests.
Time at follow-up varied widely across studies, with
follow-up ranging from 24 hours to 12 months [8]. More
time between carotid stenosis treatment and follow-up as-
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sessment is reported to be associated with greater cognitive
improvement [10, 11]. Therefore, the time-window
between treatment and follow-up might be a crucial factor
for evaluating cognitive change after carotid stenosis treat-
ment.
Regarding the emotional state of patients with carotid
artery disease, several studies indicate an improvement
after treatment of carotid stenosis: lower depression scores
were observed after CAS [12] and better mental health
scores were observed after CEA [13]. These improvements
are likely due to the emotional relief of a reduced risk of
stroke and psychological relief after uncomplicated treat-
ment [6].
In this study, we compared the long-term effects of dif-
ferent invasive revascularisation methods (CEA, CAS) and
BMT on cognition, and describe for the first time in the
literature the long-term effects of three different treatment
methods on the emotional state of patients with carotid
artery disease. Findings of cognitive or emotional long-
term improvements would support the efficacy of carotid
artery disease treatment.
Methods
Cohort and study design
Between 2009 and 2012, specialised interdisciplinary clin-
ical teams at two university hospitals recruited 95 in- or
outpatients with significant carotid stenosis (≥70%) on any
noninvasive examination (Doppler, computed tomography
angiography or magnetic resonance [MR] angiography).
Patients were considered symptomatic if a minor stroke
[14], retinal ischaemia or transient ischaemic attack (TIA)
with motor, sensory, speech or visual impairment had oc-
curred within 3 months prior to inclusion. Asymptomatic
patients were defined as having no previous minor stroke
or TIA. Patients had to consent to the study and be able to
undergo a standardised cognitive assessment and an MRI
examination before possible treatment of carotid artery dis-
ease (time point 1; TP1, as described elsewhere [1]) and at
one-year follow-up (time point 2; TP2). A one-year follow-
up period was chosen to gain insight into the long-term
outcome of patients after noninvasive treatment of carotid
artery disease.
Exclusion criteria were: major stroke, carotid stenosis
<70%, significant handicap at the time of inclusion as
measured by a modified Rankin Scale score >2, progress-
ive cerebral pathology (such as tumour, multiple sclerosis,
Alzheimer’s disease), and standard exclusion criteria for
MRI investigations. Local ethics committees of the re-
sponsible centres approved the study protocol. Written in-
formed consent was obtained from all patients prior to
study inclusion.
Clinical assessment
The degree of carotid artery stenosis was determined based
on Duplex ultrasound. Peak systolic velocities of >215 cm/
sec were graded as stenosis of ≥70%, which is equivalent to
a stenosis of ≥70% according to North American Sympto-
matic Carotid Endarterectomy Trial (NASCET) [15, 16]. If
Duplex data were unavailable, data from digital subtraction
angiography, computed tomography angiography or MR
angiography were used to grade stenoses, also according
to NASCET criteria [15]. High resolution 1.5 Tesla MRIs
were analysed to score the severity of white matter hyper-
intensities (Fazekas rating scale, Age-Related White Mat-
ter Changes (ARWMC) scale [17–19]) and to document
structural brain lesions caused by trauma, haemorrhage,
old infarction, infection or tumour, in particular in symp-
tomatic carotid artery disease (table 1). On T1 weighted
images the relative white and grey matter volumes were
calculated (Statistical Parametric Mapping 8, SPM8;
www.fil.ion.ucl.ac.uk/spm/ for MATLAB R2009a,
MathWorks, Natick, MA, USA). Collateralisation was as-
sessed by categorising the completeness of the circle of
Willis as determined on time-of-flight MR angiography im-
ages. The completeness of the circle of Willis was cat-
egorised into three groups according to Ryan et al. 2013
[20]: classical complete, hypoplastic and incomplete circle
of Willis. For details regarding the association between the
collateralisation and cognitive assessment at TP1 see [1].
The National Institute of Health Stroke Scale (NIHSS) was
assessed to evaluate the neurological status of the patients.
Vascular risk factors were assessed by physicians during an
interview (see table 1).
Cognitive assessment
The cognitive assessment comprised 13 cognitive domains
(printed below in italics). In the domain of executive func-
tions, interference control (Stroop Interference [21]), pro-
cessing speed (Symbols [22]), and verbal fluency (Animal
Naming; [23]) were assessed. Word production was as-
sessed with the Boston Naming Test [23]. Furthermore, dif-
ferent memory domains such as verbal learning, recall and
recognition (Word Rey Learning Tests; [24]), short term
memory (Digit Span Test; [22]) and visual learning, recall
and recognition (for patients >70 years Signs, [25]; for pa-
tients <70 years Rey Figure [26]) were assessed. Motor
speed (Purdue Pegboard; [27]) and emotional state (Hos-
pital Anxiety and Depression Scale [28]) were assessed
(high scores represent high anxiety and/or depression). In
all tasks higher scores reflect better performance, except
for interference control, where lower scores indicate better
performance. For a detailed description of cognitive per-
formance before treatment see [1].
Therapy
Decisions about whether and which method of treatment
was applied (CEA, CAS, BMT) were taken independently
of the study and were up to the treating physicians and pa-
tients. In both centres, published European guidelines were
followed [29]. There was a lower threshold to intervene
(CEA or CAS) in patients with recent symptoms related
to the stenosis, male patients, and high grade stenosis. In
both centres, CEA is generally preferred in symptomatic
and elderly patients. BMT included an antiplatelet agent,
statin treatment to attain a low density lipoprotein choles-
terol level ≤2.6 mmol/l, antihypertensive treatment to at-
tain a blood pressure <140/90 mm Hg (diabetics: <130/85),
strict control of hyperglycaemia if diabetic, counselling
for smoking cessation, and basic information about weight
control, regular physical exercise, and balanced nutrition.
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Statistical analysis
Statistical analyses were conducted using IBM SPSS Stat-
istics 20.0. For all cognitive, motor speed and emotional
state tests, raw scores were used for the analyses. Continu-
ous variables were tested for normal distribution using the
Kolmogorov-Smirnov test. The majority of the variables
(except interference control and verbal learning, recogni-
tion and recall) were not normally distributed. Conse-
quently, and also because of the different group sizes, non-
parametric statistics were used to evaluate all variables.
Two-sided probabilities are reported for all statistical tests.
The Bonferroni method was used to counteract type I error
caused by multiple comparisons [30]. Mann-Whitney-U
tests were analysed to identify group differences between
symptomatic and asymptomatic patients according to the
MRI. To detect group differences among the three treat-
ment groups (CEA, CAS, BMT) with regard to patient
characteristics, the Kruskal-Wallis test was applied. Differ-
ences between cognitive performance at TP1 and TP2 were
calculated using the Wilcoxon signed-rank test. Changes in
cognitive performance between TP1 and TP2 are presen-
ted as relative gain scores, and approximate effect sizes
are reported as r. The relative gain score is defined as
((TP2-TP1)/TP1). Gain score differences were analysed
with Kruskal-Wallis tests (treatment groups, education
level, side of stenosis) or Mann-Whitney-U tests (sex, con-
dition). To analyse the relationship between age, perform-
ance level at TP1 and gain scores, Spearman correlations
were performed. Sample size varied across different cog-
nitive tasks due the fact that some tasks were only per-
formed in patients ≥70 years (visual memory: Signs Learn-
ing Test) or in patients <70 years (visual memory: Rey
figure).
Results
Of 95 patients who were initially recruited into the study
at the two hospitals, 37 were excluded because of stenosis
grade <70% (n = 13), intracranial instead of extracranial
stenosis (n = 5), infarction larger than a third of the middle
cerebral artery territory (n = 3), severe stroke (n = 2), or
missing cognitive data (n = 6). One year after the first as-
sessment, two patients had died and six patients did not
want to continue in the study. Therefore, 58 patients were
retained for further analyses (43 male, 15 female; mean
age 69.4, range 51.4–85.3 years). There was no effect of
age (over all raw scores Spearman correlations p >0.05),
sex (Kruskal-Wallis tests p >0.05) or education (Mann
Whitney-U tests p >0.05) on gain scores. The number of
symptomatic or asymptomatic patients, sex, age, vascular
risk factors, relative grey and white matter volume, hyper-
intensity, NIHSS scores and cognitive performance at TP1
showed no significant differences between treatment
groups (table 2). White matter hyperintensities, and grey
and white matter volumes, did not differ between sympto-
matic and asymptomatic patients (table 1).
For all groups combined, mean time between cognitive as-
sessment and follow-up examination was 389 days (stand-
ard deviation [SD] 38, range 306–519 days). At time of
treatment, 36 patients were asymptomatic. Among the 22
patients with symptomatic carotid artery stenosis, 44.5%
had a TIA, 22.2% suffered from a minor stroke and 33.3%
had retinal ischaemia. In symptomatic patients, the time in-
terval to stroke or TIA had no influence on the gain scores
in all cognitive tasks.
In the total group of patients, the mean score of all 13 cog-
nitive tasks increased between TP1 and TP2. Significant
improvement of cognitive performance occurred in 8 out of
13 cognitive tasks (61.5%) and in motor speed (dominant
hand: Z = –2.16, p = 0.031, table 3). Emotional state did not
improve significantly between TP1 and TP2 (anxiety: Z =
–1.15, p = 0.249; depression Z = –0.06, p = 0.950).
Cognitive assessment at TP1 was performed in 20 patients
before CEA (34.5%), in 10 patients before CAS (17.2%)
and in 28 patients before BMT (48.3%). Patients of the
CAS group improved in all cognitive tasks after one year;
this was statistically significant in 4 of 13 tasks (p <0.05).
Patients with CEA also improved in all cognitive tasks;
this was statistically significant in 2 of 13 tasks (p <0.05).
Patients with BMT improved in 11 of 13 cognitive tasks;
this was statistically significant in 3 of 13 tasks (p <0.05).
However, in the BMT group, performance showed a
nonsignificant trend towards a decline in two cognitive
tasks. Gain scores did not differ significantly among the
three treatment groups in any of the cognitive tasks (see
table 4).
Women had significantly higher gain scores in visual learn-
ing than men (U = 38, Z = –2.02, p = 0.043). Age correlated
significantly with the gain score of word production (r =
–0.27, p = 0.043), verbal recognition (r = –0.31, p = 0.019),
verbal recall (r = –0.32, p = 0.014), visual learning (r =
–0.39, p = 0.047) and short term memory (r = –.26, p =
0.049), with younger patients benefitting more from treat-
ment. Presence of collaterals did not influence the gain
scores of all tests.
Performance level at TP1, mood at TP1 and motor speed at
TP1 were significantly correlated with gain scores in a neg-
ative way, such that greater improvement was observed in
patients with low performance at TP1 (interference control:
r = –0.30, p = 0.025; processing speed: r = –0.47, p <0.001;
verbal fluency: r = –0.38, p = 0.003; short term memory:
r = –.37, p = 0.004; verbal memory: r = –.45, p <0.001,
visual learning: r = –0.68, p <0.001; visual recognition: r =
–.97, p <0.001; visual Rey immediate recall: r = –0.60, p =
Table 1: Asymptomatic versus symptomatic patients.
Asymptomatic
n = 36
Symptomatic
n = 22
Group difference
Z (p-value)
ARWMC 4.37 (4.34) 4.95 (3.03) –1.01 (0.311)
Fazekas scale 0.80 (0.79) 1.14 (0.73) –1.72 (0.085)
Relative grey matter volume 1.01 (0.14) 0.99 (0.14) –0.34 (0.733)
Relative white matter volume 1.00 (0.16) 0.99 (0.13) –0.07 (0.946)
ARWMC = age-related white matter changes
Data are mean (standard deviation)
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0.001; visual Rey late recall: r = –0.38, p = 0.042; anxiety:
r = –.40, p = 0.003; depression: r = –0.45, p = 0.001, motor
speed nondominant hand: r = –.41, p = 0.002). Hence, pa-
tients with low cognitive performance, low anxiety and de-
pression or slow motor speed at TP1 benefitted most from
endarterectomy.
The side of stenosis and the presenting symptoms (asymp-
tomatic versus symptomatic) did not relate to performance
at TP1, TP2 or gain scores. Time between treatment and
follow-up was not associated with gain scores on any cog-
nitive task. However, education level correlated with inter-
ference control, verbal fluency and word production at TP1
and TP2 (all: r >0.34, p <0.05).
Discussion
The present study showed that, independent of the treat-
ment type, significant improvement of executive functions,
visual memory and motor speed can occur following treat-
ment of carotid artery disease. Following BMT, improve-
ment occurred in fewer cognitive tasks than after CEA or
CAS. However there was no significant effect of treatment
group with regard to cognitive performance level at 1-year
Table 2: Patients’ characteristics.
BMT
n = 28
CAS
n = 10
CEA
n = 20
Total
n = 58
Group differences
H(2)/(p-value)
Demographics
Age, mean (SD) 71.3 (8.1) 65.4 (9.3) 68.7 (7.9) 69.4 (8.4) 3.4 (0.18)
Male, n (%) 21 (75.0) 9 (90.0) 13 (65.0) 43 (74.1) 2.2 (0.34)
Asymptomatic, n (%) 20 (71.4) 4 (40.0) 12 (57.1) 36 (62.1) 3.1 (0.21)
Stenosis side, n (%)
Right
Left
Both
11 (39.3)
9 (32.1)
8 (28.6)
6 (60.0)
3 (30.0)
1 (10.0)
9 (45.0)
8 (40.0)
3 (10.0)
26 (44.8)
20 (34.5)
12 (20.7)
1.9 (0.39)
Vascular risk factors, n (%)
Hypertension 22 (83.3) 5 (50.0) 15 (75.0) 42 (72.4) 3.1 (0.22)
Diabetes 7 (25.0) 2 (20.0) 7 (35.0) 16 (27.6) 0.9 (0.63)
Hypercholesterolaemia 23 (82.1) 5 (50.0) 15 (75.0) 43 (74.1) 3.9 (0.14)
Coronary artery disease 10 (35.7) 6 (60.0) 6 (30.0) 23 (37.9) 2.6 (0.27)
Thrombophilia 0 0 1 (5.0) 1 (1.7) 1.9 (0.39)
Atrial fibrillation 2 (7.1) 0 2 (10.0) 4 (6.9) 1.0 (0.60)
Current smoking 5 (17.9) 2 (20.0) 5 (25.0) 12 (20.7) 0.4 (0.84)
Number of risk factors 2 (0–5) 2 (1–4) 2 (0-5) 2 (0-5) 1.7 (0.44)
Lesion analysis by structural MRI
NIHSS score 0 (0–4) 0 (0-0) 0 (0-0) 0 (0–4) 3.8 (0.15)
Grey matter volume 1.02 (0.15) 1.04 (0.07) 0.96 (0.14) 1.00 (.14) 3.9 (0.14)
White matter volume 1.01 (0.17) 1.02 (0.14) 0.97 (.12) 1.00 (1.4) 0.7 (0.70)
Faszekas scale 1 (0–3) 1 (0–3) 1 (0–2) 1 (0–3) 1.4 (0.50)
ARWMC 5.51 (4.34) 4.70 (3.55) 3.37 (3.45) 4.59 (3.88) 3.9 (0.19)
ARWMC = age-related white matter changes; BMT = best medical treatment; CAS = carotid artery stenting; CEA = carotid endarterectomy; MRI = magnetic resonance
imaging; NIHSS = National Institute of Health Stroke Scale
Data are mean (standard deviation), n (%) or median (range)
Table 3: Cognitive performance before (TP1) and after treatment (TP2; 1-year follow-up).
TP1 TP2 Z r
Interference control‡ 76.5 69.0 –2.93**† 0.39
Processing speed 19.0 21.0 –1.82 0.24
Verbal fluency 18.0 21.0 –2.69** 0.35
Word production 23.0 26.0 –2.27* 0.29
Verbal learning 37.0 36.5 –0.46 0.06
Verbal recognition 11.5 12.0 –2.10* 0.27
Verbal recall 10.0 10.0 –1.20 0.15
Short term memory 5.5 6.0 –4.20***† 0.55
Visual learning 17.5 17.0 –0.29 0.05
Visual recognition 10.0 10.0 –2.27* 0.43
Visual recall 7.0 7.5 –0.34 0.07
Visual Rey immediate recall 20.0 24.8 –2.51* 0.46
Visual Rey late recall 20.0 24.8 –3.07**† 0.57
TP1 = cognitive assessment before treatment, TP2 = cognitive assessment at 1-year follow-up
Data are median raw scores
‡ In all tasks higher scores indicate higher performance, except in interference control where higher scores mean slower performance
* p <0.05, ** p <0.01, *** p <0.001
† p remains significant after Bonferroni correction
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follow-up. These results suggest that the effects of treat-
ment type on cognition are small.
To the best of our knowledge, the present prospective study
was the first to compare the long-term effects of different
invasive revascularisation methods (CEA, CAS) and BMT
on patients’ cognitive performance. Results of several stud-
ies describing cognitive changes after treatment are con-
sistent with our findings and suggest a trend towards better
verbal memory, attention and cognitive speed after CAS
[31–33] or CEA [34], in particular in symptomatic patients
[35, 36]. A possible explanation for improved cognitive
performance after treatment of carotid artery disease is the
amelioration of haemodynamic pathology and reduction of
embolism. Perfusion restoration due to CEA, CAS or BMT
could improve cognitive dysfunction caused by a state of
chronic hypoperfusion before treatment [37]. A study com-
bining perfusion variables and cognitive scores suggested
that improvement of blood flow in the middle cerebral
artery is associated with greater cognitive improvement in
attention and executive functioning [38].
However, other studies suggest stable cognitive perform-
ance after intervention [6, 7, 11] or even a decline of cog-
nition following CEA [4]. Over the past two decades, phar-
macological management of cardiovascular disease and the
efficacy of therapy have improved. Therefore, when com-
paring studies about the treatment effects of carotid artery
disease, results of older studies must be interpreted with
caution.
Comparison of CEA and CAS showed that CEA was asso-
ciated with longer periods of ipsilateral carotid flow arrest
compared with balloon inflations used during CAS [39].
On the other hand, CAS showed a higher frequency of mi-
croembolism [40] and higher rates of new ischaemic le-
sions [41]. The present data suggest that treatment meth-
od does not influence cognitive outcome. We conclude that
transient blood flow arrest, despite the increased likelihood
of new ischaemic lesions, is not detrimental to long-term
cognitive function.
Variable study results are likely due to methodological dif-
ferences such as absence of a control group, timing of cog-
nitive testing with regard to recent symptoms and interven-
tions, use of general anaesthesia during intervention, age of
patients or differences in the follow-up time between treat-
ment and assessment. Higher age of patients (>68 years) is
suggested to be associated with a greater, more persistent
decline of cognitive functions after CEA than after CAS
[42]. Short intervals between pre-treatment and post-treat-
ment cognitive assessment may not be sufficient to detect
cognitive changes, in particular when effects of general
anaesthesia and neurological or psychological factors are
considered [5]. Furthermore, the motivation to undergo
cognitive assessment immediately after treatment is expec-
ted to be lower than at a follow-up assessment. Hence,
cognitive scores collected in the first few days after treat-
ment may not reliably reflect cognitive performance level.
Indeed, studies with short test-retest time intervals (days to
months) generally found a decline or no change in cognit-
ive performance after treatment [5, 43, 44]. In our study,
mean time between treatment and assessment was about
one year and we did not find an influence of time on cog-
nitive change after treatment.
When interpreting the present study results, it has to be
considered that new but clinically silent ischaemic lesions
after CEA or CAS could lead to additional cognitive
impairment [45]. However, a recent study found no asso-
ciation between the numbers of new lesions on diffusion
weighted imaging and cognitive performance after 6 weeks
or 3 months of follow-up [33]. The clinical significance of
new ischaemic lesions on early diffusion weighted imaging
can be questioned because of the partial reversibility of le-
sions. In addition, most lesions may be too small to cause
cognitive impairment.
Our study participants were generally free of severe cognit-
ive impairments. The homogeneity of the treatment groups,
in particular the homogeneity of the symptomatic and
asymptomatic patients with carotid artery disease, was con-
firmed by MRI (table 1). Still, patients with lower cognitive
performance and worse emotional state before treatment
benefited most from treatment, independent of treatment
type. These results highlight the functional plasticity of the
adult brain, even among patients with circumscribed mor-
phological brain lesions due to carotid artery disease.
The lack of a perfusion measure is a limitation of the
present study. Furthermore, time between treatment and
follow-up was rather long and, hence, cognitive changes
occurring immediately after treatment might not have been
Table 4: Gain scores across the treatment groups.
BMT CAS CEA H(2)/(p-value)
Interference control –0.093* –0.071 –0.017 0.40 (0.82)
Processing speed 0.042 –0.072 0.167* 2.74 (0.25)
Verbal fluency 0.088 0.053 0.163 1.10 (0.58)
Word production 0.000 0.000 0.033 0.30 (0.86)
Verbal learning –0.009 0.079 –0.028 2.29 (0.32)
Verbal recognition 0.000 0.035* 0.000 0.66 (0.72)
Verbal recall 0.000 0.056 0.097 1.72 (0.42)
Short term memory 0.083* 0.083* 0.000* 0.33 (0.85)
Visual learning –0.027 0.000 0.177 2.03 (0.36)
Visual recognition 0.000 0.000 0.000 1.41 (0.49)
Visual recall 0.000 0.000 0.222 0.69 (0.71)
Visual Rey immediate recall 0.039 0.191* 0.160 0.78 (0.68)
Visual Rey late recall 0.152* 0.269* 0.148 1.16 (0.56)
BMT = best medical treatment; CAS = carotid artery stenting; CEA = carotid endarterectomy
Data are median gain scores
* Indicates a significant improvement between first and second assessment (p <00.05)
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detected. Following minor stroke or TIA, patients classi-
fied as asymptomatic are not always truly asymptomatic;
they are still likely to show mild neurological symptoms.
A control group would strengthen the study results, as pos-
sible practice effects and spontaneous improvement could
be controlled for. However, a parallel version of the tasks
was used whenever possible.
In conclusion, treatment of carotid artery stenosis improves
long-term cognitive performance, independent of treatment
type. With the progressive ageing of the population, the
burden of cognitive impairment becomes increasingly im-
portant. It is therefore crucial to recognise cognitive im-
provement after treatment of carotid artery disease when
estimating the risks and benefits of different reperfusion
methods such as CEA, CAS or BMT.
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